推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Expert Opinion on Drug Discovery

2024年6月最新影响因子数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎点击此处反馈给我们。

按期刊名首写字母查看 EXPERT OPIN DRU最新评论：1-2个 (2021-12-30)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
 
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看：


Expert Opinion on Drug Discovery期刊基本信息Hello，您是该期刊的第26409位访客


基本信息 登录收藏
期刊名字Expert Opinion on Drug DiscoveryExpert Opinion on Drug Discovery

EXPERT OPIN DRUG DIS
（此期刊被最新的JCR期刊SCIE收录）

LetPub评分
7.3
50人评分
我要评分

声誉
8.8

影响力
6.3

速度
7.0

期刊ISSN1746-0441
微信扫码收藏此期刊
E-ISSN1746-045X
2023-2024最新影响因子
（数据来源于搜索引擎）		6 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日：3.427
2023-2024自引率1.70%点击查看自引率趋势图
五年影响因子6.6
JCI期刊引文指标 0.7
h-index 50
CiteScore
（ 2024年最新版）
CiteScoreSJRSNIPCiteScore排名
10.201.0771.176
学科分区排名百分位
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Drug Discovery		Q120 / 157

期刊简介
Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The Editors welcome:

Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biology
Drug Case Histories examining the steps involved in the preclinical and clinical development of a particular drug
The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.
期刊官方网站http://www.tandfonline.com/toc/iedc20/current
期刊投稿网址https://mc.manuscriptcentral.com/eodc
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Expert Opinion on Drug Discovery的语言要求，还能让Expert Opinion on Drug Discovery编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Expert Opinion on Drug Discovery编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿
是否OA开放访问No
通讯方式INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ
出版商Informa Healthcare
涉及的研究方向医学-药学
出版国家或地区ENGLAND
出版语言English
出版周期Bimonthly
出版年份2006
年文章数 103点击查看年文章数趋势图
Gold OA文章占比13.86%
研究类文章占比：
文章 ÷（文章 + 综述）		21.36%
WOS期刊SCI分区
（ 2023-2024年最新版）		WOS分区等级：1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科：PHARMACOLOGY & PHARMACYSCIEQ129/354
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科：PHARMACOLOGY & PHARMACYSCIEQ2163/354
中国科学院《国际期刊预警
名单（试行）》名单 		2024年02月发布的2024版：不在预警名单中

2023年01月发布的2023版：不在预警名单中

2021年12月发布的2021版：不在预警名单中

2020年12月发布的2020版：不在预警名单中
中国科学院SCI期刊分区
（ 2023年12月最新升级版） 		点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区2区1区
PHARMACOLOGY & PHARMACY
药学		2区4区2区
否是
中国科学院SCI期刊分区
（ 2022年12月升级版）
大类学科小类学科Top期刊综述期刊
医学 2区2区1区
PHARMACOLOGY & PHARMACY
药学		4区1区2区
否是
中国科学院SCI期刊分区
（ 2021年12月旧的升级版）
大类学科小类学科Top期刊综述期刊
医学 3区3区2区
PHARMACOLOGY & PHARMACY
药学		1区3区3区
否是
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1746-0441%5BISSN%5D
平均审稿速度网友分享经验：
较慢,6-12周
平均录用比例网友分享经验：
较易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Expert Opinion on Drug Discovery顺利发表。
快看看作者怎么说吧：服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Expert Opinion on Drug Discovery期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Expert Opinion on Drug Discovery中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Expert Opinion on Drug Discovery上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    PHARMACOLOGICAL REVIEWS21034.70
    DRUG RESISTANCE UPDATES10026.20
    ADVANCED DRUG DELIVERY REVIEWS27828.10
    TRENDS IN PHARMACOLOGICAL SCIENCES20123.90
    PHARMACOLOGY & THERAPEUTICS18023.00
    MEDICINAL RESEARCH REVIEWS11929.30
    PHARMACOLOGICAL RESEARCH11818.70
    ARCHIVES OF PHARMACAL RESEARCH7513.40
    BIOMEDICINE & PHARMACOTHERAPY7811.90
    BRITISH JOURNAL OF PHARMACOLOGY19015.40
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE677320
    BIOMATERIALS567016
    BIOMEDICINE & PHARMACOTHERAPY551721
    Frontiers in Pharmacology515525
    Journal of Materials Chemistry B506403
    Frontiers in Immunology492230
    COMPUTERS IN BIOLOGY AND MEDICINE474054
    JOURNAL OF ETHNOPHARMACOLOGY466427
    COLLOIDS AND SURFACES B-BIOINTERFACES438646
    Frontiers in Oncology436282
  •  

    Expert Opinion on Drug Discovery Expert Opinion on Drug Discovery
    我来预测明年：
    稳步上升 表现平稳 逐渐下降　 刷新
  •  

    		  
  •  

    		  
  •  

    		  
  • 中国学者近期发表的论文
    1.The discovery and design of novel HIV-1 capsid modulators and future perspectives

    Author: Ding, Dang; Xu, Shujing; Zhang, Xujie; Jiang, Xiangyi; Cocklin, Simon; Dick, Alexej; Zhan, Peng; Liu, Xinyong
    Journal: EXPERT OPINION ON DRUG DISCOVERY. 2023; Vol. 18, Issue 1, pp. 5-12. DOI: 10.1080/17460441.2023.2157401        PubMed      DOI
    2.Latest developments in engineered skeletal muscle tissues for drug discovery and development

    Author: Ostrovidov, Serge; Ramalingam, Murugan; Bae, Hojae; Orive, Gorka; Fujie, Toshinori; Shi, Xuetao; Kaji, Hirokazu
    Journal: EXPERT OPINION ON DRUG DISCOVERY. 2023; Vol. 18, Issue 1, pp. 47-63. DOI: 10.1080/17460441.2023.2160438        PubMed      DOI
    3.Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets

    Author: Yang, Tao; Wang, Si Chun; Ye, Linyan; Maimaitiyiming, Yasen; Naranmandura, Hua
    Journal: EXPERT OPINION ON DRUG DISCOVERY. 2023; Vol. 18, Issue 3, pp. 247-268. DOI: 10.1080/17460441.2023.2175812        PubMed      DOI
    4.Computational approaches for the design of modulators targeting protein-protein interactions

    Author: Rehman, Ashfaq Ur; Khurshid, Beenish; Ali, Yasir; Rasheed, Salman; Wadood, Abdul; Ng, Ho-Leung; Chen, Hai-Feng; Wei, Zhiqiang; Luo, Ray; Zhang, Jian
    Journal: EXPERT OPINION ON DRUG DISCOVERY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/17460441.2023.2171396        PubMed      DOI
    5.An approach combining deep learning and molecule docking for drug discovery of cathepsin L

    Author: Li, Qi; Wang, Hao; Yang, Wei-Li; Yang, Jin-Kui
    Journal: EXPERT OPINION ON DRUG DISCOVERY. 2023; Vol. 18, Issue 3, pp. 347-356. DOI: 10.1080/17460441.2023.2174522        PubMed      DOI
    6.Advances in determining new treatments for hepatitis B infection by utilizing existing and novel biomarkers

    Author: Mak, Lung-Yi; Hui, Rex Wan-Hin; Cheung, Ka-Shing; Fung, James; Seto, Wai-Kay; Yuen, Man-Fung
    Journal: EXPERT OPINION ON DRUG DISCOVERY. 2023; Vol. 18, Issue 4, pp. 401-416. DOI: 10.1080/17460441.2023.2192920        PubMed      DOI
    7.Challenges with the discovery of RNA-based therapeutics for flaviviruses

    Author: Wang, Mei-Yue; Zhao, Rong; Wang, Yu-Lan; Wang, De-Ping; Cao, Ji-Min
    Journal: EXPERT OPINION ON DRUG DISCOVERY. 2023; Vol. 18, Issue 4, pp. 371-383. DOI: 10.1080/17460441.2023.2195164        PubMed      DOI
    8.Optimization techniques for novel c-Met kinase inhibitors.

    Author: Sun ZG1,2, Yang YA2, Zhang ZG3, Zhu HL2.
    Journal: Expert Opin Drug Discov. 2019 Jan;14(1):59-69. doi: 10.1080/17460441.2019.1551355. Epub 2018 Dec 5.        PubMed      DOI
    9.Animal models of major depressive disorder and the implications for drug discovery and development.

    Author: Demin KA1,2, Sysoev M3,4, Chernysh MV2, Savva AK5, Koshiba M6, Wappler-Guzzetta EA7, Song C8,9, De Abreu MS10, Leonard B11, Parker MO12, Harvey BH13, Tian L14, Vasar E14, Strekalova T15,16,17, Amstislavskaya TG18, Volgin AD7,18, Alpyshov ET19, Wang D19, Kalueff AV19,20,21,22,23,24,25,26.
    Journal: Expert Opin Drug Discov. 2019 Apr;14(4):365-378. doi: 10.1080/17460441.2019.1575360. Epub 2019 Feb 22.        PubMed      DOI
    10.Are we seeing a resurgence in the use of natural products for new drug discovery?

    Author: Li F1, Wang Y1, Li D1, Chen Y1, Dou QP2.
    Journal: Expert Opin Drug Discov. 2019 May;14(5):417-420. doi: 10.1080/17460441.2019.1582639. Epub 2019 Feb 27.        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity069.90
    Living Reviews in Relativity7569.90
    Advanced Composites and Hybrid Materials026.00
    Kidney International Supplements2026.70
    Kidney International Supplements2426.70
    Wiley Interdisciplinary Reviews-Computational Molecular Science6228.90
    Military Medical Research038.40
    NUCLEIC ACIDS RESEARCH45227.10
    Environmental Chemistry Letters5032.00
    Journal of the National Comprehensive Cancer Network8820.20
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分：

同领域作者分享投稿经验：共5条


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）

    增值电信业务经营许可证：沪B2-20211595    网络文化经营许可证：沪网文[2023]2004-152号

    礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室